Knowledge

The FDA has renewed modified risk tobacco product (MRTP) orders for eight General Snus products, allowing continued marketing with claims of lower health risks compared to cigarettes. This renewal is based on scientific evidence showing that exclusive use reduces harm related to mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis, while not …

Nicotine pouches are transforming adult nicotine use by offering a smoke-free, discreet alternative to traditional cigarettes. Brands like ZYLO provide on-the-go options with no smoke, odor, or tobacco leaf, available in multiple flavors and strengths. These pouches are gaining popularity for convenience, flexibility, and a cleaner nicotine experience, supported by loyalty programs, bundles, and subscription …

Nicotine pouch use in the UK has increased dramatically over the past five years, particularly among young adults aged 16 to 24. Research shows that nearly 700,000 Britons now use nicotine pouches, driven by discreet convenience, flavor variety, and the appeal of a smoke-free experience. Brands like ZYLO are leading the market with high-quality, modern …

Modified Risk Tobacco Products (MRTPs) are tobacco products marketed with claims of reduced harm or risk of tobacco-related disease. Companies seeking MRTP authorization must demonstrate that their product benefits individual users and public health. The FDA evaluates scientific evidence, public comments, and population impact before approving, denying, or conditioning the marketing of these products. ZYLO …

Nicotine pouches are rapidly gaining popularity among young men in Great Britain, with usage rates significantly higher than in other demographics. These small, discreet pouches deliver nicotine without tobacco smoke or odor, appealing to users seeking a convenient alternative to traditional smoking. Brands like ZYLO provide a range of flavors and strengths, supporting smoke-free nicotine …

Philip Morris International is poised for a major shift in 2026 as smoke-free products gain traction globally. With its strategic expansion into the U.S. market via ZYLO and Iqos Iluma, the company is converting traditional smokers to cleaner alternatives, boosting revenue streams, and positioning itself as a leader in nicotine innovation. This transformation could redefine …

The FDA has authorized six nicotine pouch products under a new streamlined review program, signaling a shift in how smoke-free nicotine alternatives are evaluated in the United States. This decision expands legal market options for adult users, reinforces public health oversight, and highlights growing demand for tobacco-free formats similar to modern brands like ZYLO that …

Since the Tobacco Control Act reshaped U.S. regulation, the oral tobacco and nicotine market has shifted from traditional smokeless products toward modern, tobacco-free alternatives. Sales data from 2009–2024 show declining moist snuff dominance, slowing snus growth, and rapid expansion of nicotine pouches. Flavor variety, regulatory oversight, and consumer demand for smoke-free convenience now define this …

The Modified Risk Tobacco Product pathway exists to ensure adult smokers receive accurate, science-based information about lower-risk nicotine alternatives. It allows regulators to evaluate whether smoke-free products meaningfully reduce harm compared to cigarettes while safeguarding public health. When properly applied, this pathway supports smoking reduction, informed consumer choice, and responsible innovation across modern nicotine brands …